PLRX · Pliant Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Third Rock Ventures III, L.P. 10% Owner | ▼ Sell | Other | 1,839,160 Shares held | 11/29/2022 | View profile |
| Bernard Coulie President and CEO | ▼ Sell | Open Market | 505,601 Shares held | 1/20/2026 | View profile |
| Keith Lamont Cummings Chief Financial Officer | ▼ Sell | Open Market | 297,214 Shares held | 1/20/2026 | View profile |
| Hans Hull Chief Business Officer | ▲ Buy | Grant | 251,708 Shares held | 1/23/2025 | View profile |
| Eric Lefebvre Chief Medical Officer | ▲ Buy | Grant | 240,224 Shares held | 1/23/2025 | View profile |
| Mike Ouimette General Counsel & Corp. Sec'y | ▲ Buy | Grant | 105,544 Shares held | 1/23/2025 | View profile |
| Lily Cheung Chief Human Resource Officer | ▼ Sell | Open Market | 44,847 Shares held | 1/20/2026 | View profile |
| Minnie Kuo Chief Operating Officer | ▼ Sell | Open Market | 37,806 Shares held | 1/20/2026 | View profile |
Transaction History
| Bernard Coulie | ▼ Sell | Open Market | 89,375 | $114K | 1/20/2026 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 24,002 | $31K | 1/20/2026 |
| Lily Cheung | ▼ Sell | Open Market | 7,534 | $10K | 1/20/2026 |
| Minnie Kuo | ▼ Sell | Open Market | 6,917 | $9K | 1/20/2026 |
| Lily Cheung | ▲ Buy | Grant | 25,875 | $0 | 1/23/2025 |
| Mike Ouimette | ▲ Buy | Grant | 35,000 | $0 | 1/23/2025 |
| Hans Hull | ▲ Buy | Grant | 40,150 | $0 | 1/23/2025 |
| Eric Lefebvre | ▲ Buy | Grant | 45,650 | $0 | 1/23/2025 |
| Keith Lamont Cummings | ▲ Buy | Grant | 56,650 | $0 | 1/23/2025 |
| Bernard Coulie | ▲ Buy | Grant | 162,500 | $0 | 1/23/2025 |
| Mike Ouimette | ▼ Sell | Open Market | 10,230 | $112K | 1/22/2025 |
| Mike Ouimette | ▼ Sell | Open Market | 13,270 | $149K | 1/17/2025 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 20,148 | $226K | 1/17/2025 |
| Hans Hull | ▼ Sell | Open Market | 15,936 | $179K | 1/17/2025 |
| Eric Lefebvre | ▼ Sell | Open Market | 18,478 | $207K | 1/17/2025 |
| Lily Cheung | ▼ Sell | Open Market | 3,740 | $42K | 1/17/2025 |
| Bernard Coulie | ▼ Sell | Open Market | 52,419 | $587K | 1/17/2025 |
| Bernard Coulie | ▼ Sell | Open Market | 38,710 | $447K | 7/10/2024 |
| Eric Lefebvre | ▼ Sell | Open Market | 12,319 | $142K | 7/10/2024 |
| Mike Ouimette | ▼ Sell | Open Market | 7,656 | $89K | 7/10/2024 |
| Hans Hull | ▼ Sell | Open Market | 9,900 | $114K | 7/10/2024 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 10,911 | $126K | 7/10/2024 |
| Hans Hull | ▲ Buy | Grant | 19,337 | $0 | 7/9/2024 |
| Eric Lefebvre | ▲ Buy | Grant | 24,063 | $0 | 7/9/2024 |
| Keith Lamont Cummings | ▲ Buy | Grant | 21,313 | $0 | 7/9/2024 |
| Bernard Coulie | ▲ Buy | Grant | 75,625 | $0 | 7/9/2024 |
| Mike Ouimette | ▲ Buy | Grant | 14,954 | $0 | 7/9/2024 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 21,000 | $44K | 5/2/2024 |
| Eric Lefebvre | ▲ Buy | Grant | 42,900 | $0 | 1/23/2024 |
| Hans Hull | ▲ Buy | Grant | 31,500 | $0 | 1/23/2024 |
| Mike Ouimette | ▲ Buy | Grant | 31,500 | $0 | 1/23/2024 |
| Keith Lamont Cummings | ▲ Buy | Grant | 55,250 | $0 | 1/23/2024 |
| Lily Cheung | ▲ Buy | Grant | 26,000 | $0 | 1/23/2024 |
| Bernard Coulie | ▲ Buy | Grant | 128,150 | $0 | 1/23/2024 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 9,781 | $169K | 1/17/2024 |
| Hans Hull | ▼ Sell | Open Market | 9,786 | $169K | 1/17/2024 |
| Bernard Coulie | ▼ Sell | Open Market | 25,721 | $443K | 1/17/2024 |
| Eric Lefebvre | ▼ Sell | Open Market | 10,295 | $177K | 1/17/2024 |
| Mike Ouimette | ▼ Sell | Open Market | 5,197 | $90K | 1/17/2024 |
| Hans Hull | ▲ Buy | Option Exercise | 8,791 | $18K | 8/4/2023 |
| Hans Hull | ▼ Sell | Open Market | 20,050 | $401K | 8/4/2023 |
| Hans Hull | ▼ Sell | Open Market | 13,069 | $261K | 8/3/2023 |
| Hans Hull | ▲ Buy | Option Exercise | 1,800 | $4K | 8/3/2023 |
| Hans Hull | ▼ Sell | Open Market | 1,800 | $36K | 8/3/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 4,755 | $83K | 7/20/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 70,150 | $1.3M | 7/17/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 12,778 | $230K | 7/17/2023 |
| Eric Lefebvre | ▼ Sell | Open Market | 22,321 | $402K | 7/17/2023 |
| Hans Hull | ▼ Sell | Open Market | 17,937 | $323K | 7/17/2023 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 19,771 | $356K | 7/17/2023 |
| Mike Ouimette | ▲ Buy | Grant | 27,187 | $0 | 7/14/2023 |
| Eric Lefebvre | ▲ Buy | Grant | 43,750 | $0 | 7/14/2023 |
| Hans Hull | ▲ Buy | Grant | 35,156 | $0 | 7/14/2023 |
| Keith Lamont Cummings | ▲ Buy | Grant | 38,750 | $0 | 7/14/2023 |
| Bernard Coulie | ▲ Buy | Grant | 137,500 | $0 | 7/14/2023 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 30,750 | $64K | 6/13/2023 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 5,800 | $12K | 6/9/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 2,677 | $72K | 4/3/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 200 | $5K | 4/3/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 4,874 | $129K | 3/30/2023 |
| Eric Lefebvre | ▼ Sell | Open Market | 11,245 | $298K | 3/30/2023 |
| Hans Hull | ▼ Sell | Open Market | 9,036 | $240K | 3/30/2023 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 9,960 | $264K | 3/30/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 35,339 | $937K | 3/30/2023 |
| Bernard Coulie | ▲ Buy | Grant | 68,749 | $0 | 3/29/2023 |
| Keith Lamont Cummings | ▲ Buy | Grant | 19,375 | $0 | 3/29/2023 |
| Mike Ouimette | ▲ Buy | Grant | 13,593 | $0 | 3/29/2023 |
| Eric Lefebvre | ▲ Buy | Grant | 21,874 | $0 | 3/29/2023 |
| Hans Hull | ▲ Buy | Grant | 17,578 | $0 | 3/29/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $93K | 2/3/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 9,738 | $325K | 2/3/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 5,262 | $179K | 2/3/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $93K | 2/2/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 13,395 | $457K | 2/2/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 1,605 | $56K | 2/2/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $93K | 2/1/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 9,455 | $323K | 2/1/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 5,440 | $189K | 2/1/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 105 | $4K | 2/1/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 10,539 | $22K | 1/31/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 4,461 | $28K | 1/31/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $524K | 1/31/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/30/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 11,395 | $387K | 1/30/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 3,605 | $125K | 1/30/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/27/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 8,698 | $308K | 1/27/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 6,302 | $227K | 1/27/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 9,779 | $343K | 1/27/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 221 | $8K | 1/27/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $529K | 1/26/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $526K | 1/26/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/26/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/25/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 13,304 | $431K | 1/25/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 1,696 | $56K | 1/25/2023 |
| Keith Lamont Cummings | ▲ Buy | Grant | 54,000 | $0 | 1/25/2023 |
| Hans Hull | ▲ Buy | Grant | 54,000 | $0 | 1/25/2023 |
| Mike Ouimette | ▲ Buy | Grant | 39,000 | $0 | 1/25/2023 |
| Eric Lefebvre | ▲ Buy | Grant | 57,000 | $0 | 1/25/2023 |
| Bernard Coulie | ▲ Buy | Grant | 146,300 | $0 | 1/25/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $463K | 1/24/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/24/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 10,150 | $342K | 1/23/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/23/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 4,850 | $169K | 1/23/2023 |
| Mike Ouimette | ▲ Buy | Option Exercise | 10,000 | $119K | 1/23/2023 |
| Mike Ouimette | ▲ Buy | Option Exercise | 10,000 | $243K | 1/23/2023 |
| Mike Ouimette | ▼ Sell | Open Market | 20,000 | $684K | 1/23/2023 |
| Eric Lefebvre | ▼ Sell | Open Market | 67,500 | $2.3M | 1/23/2023 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 12,500 | $26K | 1/23/2023 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 17,500 | $109K | 1/23/2023 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 30,000 | $1.1M | 1/23/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $525K | 1/23/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 5,000 | $10K | 1/9/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 5,000 | $96K | 1/9/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/6/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $286K | 1/6/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/4/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $286K | 1/4/2023 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 1/3/2023 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $290K | 1/3/2023 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 4,000 | $8K | 12/22/2022 |
| Mike Ouimette | ▼ Sell | Open Market | 2,928 | $57K | 12/22/2022 |
| Keith Lamont Cummings | ▼ Sell | Open Market | 9,643 | $184K | 12/20/2022 |
| Bernard Coulie | ▼ Sell | Open Market | 34,212 | $654K | 12/20/2022 |
| Eric Lefebvre | ▼ Sell | Open Market | 10,887 | $208K | 12/20/2022 |
| Mike Ouimette | ▼ Sell | Open Market | 4,719 | $90K | 12/20/2022 |
| Hans Hull | ▼ Sell | Open Market | 8,748 | $167K | 12/20/2022 |
| Bernard Coulie | ▲ Buy | Grant | 68,751 | $0 | 12/19/2022 |
| Eric Lefebvre | ▲ Buy | Grant | 21,876 | $0 | 12/19/2022 |
| Mike Ouimette | ▲ Buy | Grant | 13,594 | $0 | 12/19/2022 |
| Hans Hull | ▲ Buy | Grant | 17,578 | $0 | 12/19/2022 |
| Keith Lamont Cummings | ▲ Buy | Grant | 19,375 | $0 | 12/19/2022 |
| Third Rock Ventures III, L.P. | ▼ Sell | Other | 2,000,000 | — | 11/29/2022 |
| Eric Lefebvre | ▼ Sell | Open Market | 5,000 | $125K | 10/25/2022 |
| Third Rock Ventures III, L.P. | ▼ Sell | Other | 2,000,000 | — | 9/20/2022 |
| Bernard Coulie | ▲ Buy | Option Exercise | 12,502 | $26K | 9/12/2022 |
| Bernard Coulie | ▼ Sell | Open Market | 12,502 | $282K | 9/12/2022 |
| Bernard Coulie | ▲ Buy | Option Exercise | 12,498 | $26K | 7/12/2022 |
| Bernard Coulie | ▼ Sell | Open Market | 12,498 | $281K | 7/12/2022 |
| Eric Lefebvre | ▼ Sell | Open Market | 3,000 | $60K | 7/11/2022 |
| Bernard Coulie | ▲ Buy | Option Exercise | 15,000 | $31K | 7/11/2022 |
| Bernard Coulie | ▼ Sell | Open Market | 15,000 | $338K | 7/11/2022 |
| Keith Lamont Cummings | ▲ Buy | Option Exercise | 20,000 | $42K | 9/3/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Pliant Therapeutics Names New Chief Medical Officer
Pliant Therapeutics has appointed David Raben, M.D., as its new Chief Medical Officer. This leadership change is a standard corporate update for the company. The stock is currently trading within its 52-week range, with recent technical indicators showing a support rejection near $1.13.
Pliant Therapeutics Names New Chief Medical Officer. Pliant Therapeutics has appointed David Raben, M.D., as its new Chief Medical Officer. This leadership change is a standard corporate update for the company. The stock is currently trading within its 52-week range, with recent technical indicators showing a support rejection near $1.13.